Plain language summary of isatuximab plus carfilzomib, lenalidomide, and dexamethasone for the treatment of people with high-risk newly diagnosed multiple myeloma
Related Research units
Bibliographical data
Original language | English |
---|---|
ISSN | 1479-6694 |
DOIs | |
Publication status | Published - 30.09.2024 |